These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22109745)

  • 41. A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck.
    Johnson JT; Wagner RL; Myers EN
    Cancer; 1996 Jan; 77(1):181-5. PubMed ID: 8630927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of occult nodal metastases on survival and regional control in patients with head and neck squamous cell carcinoma.
    Gourin CG; Conger BT; Porubsky ES; Sheils WC; Bilodeau PA; Coleman TA
    Laryngoscope; 2008 Jul; 118(7):1191-4. PubMed ID: 18391764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph node metastasis burden identifies head and neck squamous cell carcinoma patients benefiting from adjuvant chemoradiation: A propensity score-matching.
    Li P; Fang Q; Yuan J; Luo R
    Eur J Surg Oncol; 2024 Jul; 50(7):108453. PubMed ID: 38824815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients.
    León X; Rigó A; Farré N; López M; García J; de Juan J; Quer M
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):527-533. PubMed ID: 27509897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapy.
    Chua MS; Veness MJ; Morgan G; Shakespeare T; Hehir A; Gebski V; Cakir B; Tiver KW
    Australas Radiol; 2002 Jun; 46(2):174-9. PubMed ID: 12060157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
    Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
    J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Tseros EA; Gebski V; Morgan GJ; Veness MJ
    Ann Surg Oncol; 2016 May; 23(5):1693-8. PubMed ID: 26786095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
    Krstevska V
    J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma.
    Warren TA; Panizza B; Porceddu SV; Gandhi M; Patel P; Wood M; Nagle CM; Redmond M
    Head Neck; 2016 Jun; 38(6):824-31. PubMed ID: 25546817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome predictors in squamous cell carcinoma of the maxillary alveolus and hard palate.
    Eskander A; Givi B; Gullane PJ; Irish J; Brown D; Gilbert RW; Hope A; Weinreb I; Xu W; Goldstein DP
    Laryngoscope; 2013 Oct; 123(10):2453-8. PubMed ID: 23553191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage.
    Al-Othman MO; Mendenhall WM; Amdur RJ
    Am J Otolaryngol; 2001; 22(6):387-90. PubMed ID: 11713722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic significance of extra-capsular invasion in cervical lymph node metastases of squamous epithelial carcinoma].
    Steinhart H; Schroeder HG; Buchta B; Schmidt A; Kleinsasser O
    Laryngorhinootologie; 1994 Dec; 73(12):620-5. PubMed ID: 7840823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
    BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
    Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
    Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of locoregional recurrence in cutaneous squamous cell carcinoma of the head and neck.
    Strassen U; Hofauer B; Jacobi C; Knopf A
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):501-506. PubMed ID: 27498202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
    Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
    Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
    Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
    Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
    Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
    JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.